Immunosuppression in experimental Junin virus infection of mice.
The effects of cyclophosphamide (CY), anti-mouse thymocyte sera, oxisuran, and cytosine arabinoside were evaluated in adult and newborn mice infected with Junin virus. Treatment with CY was the most effective, Adult mice, which are not normally susceptible to intracerebral infection with 10(3) LD50 of Junin virus, were rendered susceptible by treatment with an adequate dose and schedule of CY. However, CY-treated newborn mice were protected from death. This animal model may be suitable for use in pathogenesis and protection studies.
D000367:Age Factors; D000818:Animals; D000961:Antilymphocyte Serum / Q000494:pharmacology; D006477:Arenaviruses, New World; D003520:Cyclophosphamide / Q000494:pharmacology; D003561:Cytarabine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D006478:Hemorrhagic Fever, American / Q000276:immunology*; D007165:Immunosuppression Therapy; D051379:Mice; D008807:Mice, Inbred BALB C; D011725:Pyridines / Q000494:pharmacology; D013601:T-Lymphocytes / Q000276:immunology
D000961:Antilymphocyte Serum; D011725:Pyridines; D003561:Cytarabine; D003520:Cyclophosphamide; C100291:oxisuran